News related to Tasigna (Nilotinib) and/or conditions it is approved for
Two-pronged attack on chemotherapy-resistant leukemia cells
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.05.19]
All stems from malignant transformed precursor lymphocytes, the blood's defense cells. Nowadays, four out of five young leukemia patients can be treated successfully with aggressive chemotherapy.
Study: 93 percent of advanced leukemia patients in remission after immunotherapy
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.04.28]
'Extraordinary' but short-term results from early-stage trial of engineered immune cells.
Risk factors identified for acute pancreatitis that can disrupt leukemia treatment
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.04.26]
Researchers have identified a rare genetic variation associated with a dramatically increased risk of severe acute pancreatitis in acute lymphoblastic leukemia (ALL) patients treated with the...
FDA approves new drug for chronic lymphocytic leukemia in patients with a specific chromosomal abnormality
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.04.12]
The U.S. Food and Drug Administration has approved Venclexta (venetoclax) for the treatment of patients with chronic lymphocytic leukemia (CLL) who have a chromosomal abnormality called 17p...
New mouse model for acute myeloid leukemia opens door to research, possible treatments
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.03.31]
A novel mouse model of a highly lethal form of acute myeloid leukemia (AML) offers a new tool for scientists working to better understand this disease and research new therapeutic targets.
Source: MedicineNet Carpal Tunnel Syndrome Specialty [2016.02.03]
Category: Diseases and Conditions
Created: 12/31/1997 12:00:00 AM
Last Editorial Review: 2/3/2016 12:00:00 AM
Could Common Diabetes Drugs Help Fight Leukemia?
Source: MedicineNet pioglitazone Specialty [2015.09.03]
Title: Could Common Diabetes Drugs Help Fight Leukemia?
Category: Health News
Created: 9/2/2015 12:00:00 AM
Last Editorial Review: 9/3/2015 12:00:00 AM
New benchmark study of unrelated bone marrow transplantation for leukemia
Source: The Doctors Lounge - Hematology
Researchers at the University of Minnesota led the largest study to date in patients with leukemia undergoing bone marrow transplantation from unrelated donors.
Rituximab Plus Bendamustine vs Standard Therapy for CLL
Source: Medscape Hematology-Oncology Headlines [2016.05.27]
For patients with chronic lymphocytic leukemia (CLL), the combination of rituximab plus bendamustine was less effective than standard therapy, but it was also less toxic.
Medscape Medical News
Study links residential radon exposure to hematologic cancers in women
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.04.29]
A new report finds a statistically-significant, positive association between high levels of residential radon and the risk of hematologic cancer (lymphoma, myeloma, and leukemia) in women.
New hope for a type 2 diabetes cure
Source: Lymphoma / Leukemia / Myeloma News From Medical News Today [2016.03.29]
Leukemia drug holds promise for patients with type 2 diabetes.The cancer treatment drug Imatinib, otherwise known as Gleevec is approved to treat various forms of cancer, mostly notably chronic...